Keyword: generics

News

Abbott Results Bode Well for Spun-off AbbVie

24.01.2013 - AbbVie, the new branded pharmaceuticals company spun off by Abbott Laboratories, is off to a good start, judging by fourth-quarter sales of arthritis drug Humira and other products...

News

Eli Lilly Banks on Cost Controls for Higher 2013 Profit

04.01.2013 - Eli Lilly said on Friday it expects profit in 2013 to increase by more than Wall Street had been forecasting, primarily due to cost controls and improved productivity. Lilly, whose...

News

US FDA New Drug Approvals Hit 16-Year High in 2012

02.01.2013 - U.S. regulators approved 39 new drugs in 2012, the most in 16 years, suggesting that pharmaceutical makers are poised for growth after losing billions of dollars in recent years to...

News

Number of New Drugs Picks Up in Europe and U.S.

19.12.2012 - The number of new medicines approved or pending approval is on the rise on both sides of the Atlantic, painting an encouraging picture for the global drugs industry as it emerges...

News

With Teva at Crossroads, New CEO Set to Unveil Vision

06.12.2012 - Teva Pharmaceutical Industries' new Chief Executive Jeremy Levin has promised investors it will be a very different company going forward. Next week he has to prove it. Levin's...

News

Top EU Court Upholds AstraZeneca Fine Over Ulcer Drug

06.12.2012 - The European Union's highest court has upheld a €52.5 million ($69 million) antitrust fine levied against AstraZeneca for blocking the entry of cheaper rivals to its then...

News

Teva's 2013 Forecast Is Below Wall Street Estimates

30.11.2012 - Teva Pharmaceutical Industries, the world's biggest maker of generic drugs, forecast profit and revenue for calendar 2013 that fell short of analysts' estimates. The Israel-based...

News

Bayer Sues Lupin Over Generic Birth Control Pill

30.11.2012 - German drugmaker Bayer has filed a lawsuit in the United States against Indian generic drug maker Lupin, to prevent it from selling a version of Bayer's birth control pill Natazia...